Development of phosphonate-terminated magnetic mesoporous silica nanoparticles for pH-controlled release of doxorubicin and improved tumor accumulation

In this study, phosphonate-terminated magnetic mesoporous nanoparticles (pMMSNs) was designed by incorporation of MNPs in the center of mesoporous silica nanoparticles (MSNs) and followed by grafting phosphonate group on to the surface of MMSNs. The carrier exhibited a typical superparamagnetic feat...

Full description

Bibliographic Details
Main Authors: Erxi Che, Long Wan, Ying Zhang, Qinfu Zhao, Xiling Han, Jia Li, Jia Liu, Siling Wang
Format: Article
Language:English
Published: Elsevier 2014-12-01
Series:Asian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1818087614000531
id doaj-63475273a20f49bfab94f7ef308238dc
record_format Article
spelling doaj-63475273a20f49bfab94f7ef308238dc2020-11-25T00:50:41ZengElsevierAsian Journal of Pharmaceutical Sciences1818-08762014-12-019631732310.1016/j.ajps.2014.07.003Development of phosphonate-terminated magnetic mesoporous silica nanoparticles for pH-controlled release of doxorubicin and improved tumor accumulationErxi CheLong WanYing ZhangQinfu ZhaoXiling HanJia LiJia LiuSiling WangIn this study, phosphonate-terminated magnetic mesoporous nanoparticles (pMMSNs) was designed by incorporation of MNPs in the center of mesoporous silica nanoparticles (MSNs) and followed by grafting phosphonate group on to the surface of MMSNs. The carrier exhibited a typical superparamagnetic feature and the saturation magnetization was 4.89 emu/g measured by vibrating sample magnetometer (VSM). pMMSNs had a spherical morphology and a pore size of 2.2 nm. From N2 adsorption-desorption analysis, pMMSNs had a surface area of 613.4 m2/g and a pore volume of 0.78 cm3/g. Phosphonate modification improved the colloidal stability of MMSNs, and the hydrodynamic diameter of pMMSNs was around 175 nm. The hydrophilic phosphonate group significantly enhanced the negative surface charge of MMSNs from −19.3 mV to −28.8 mV pMMSNs with more negative surface charge had a 2.3-fold higher drug loading capacity than that of MMSNs. In addition, the rate and amount of release of doxorubicin (DOX) from DOX/pMMSNs was pH-dependent and increased with the decrease of pH. At pH 7.4, the release amount was quite low and only approximately 17 wt% of DOX was released in 48 h. At pH 5.0 and 3.0, the release rate increased significantly and the release amount achieved 31 wt% and 60 wt% in 48 h, respectively. To evaluate the magnetic targeting performance of pMMSNs, FITC labeled pMMSNs was injected into mice bearing S180 solid tumor. FITC labeled pMMSNs controlled by an external magnetic field showed higher tumor accumulation and lower normal tissue distribution.http://www.sciencedirect.com/science/article/pii/S1818087614000531Magnetic mesoporous silica nanoparticlesDoxorubicinpH-depended releaseTumor accumulation
collection DOAJ
language English
format Article
sources DOAJ
author Erxi Che
Long Wan
Ying Zhang
Qinfu Zhao
Xiling Han
Jia Li
Jia Liu
Siling Wang
spellingShingle Erxi Che
Long Wan
Ying Zhang
Qinfu Zhao
Xiling Han
Jia Li
Jia Liu
Siling Wang
Development of phosphonate-terminated magnetic mesoporous silica nanoparticles for pH-controlled release of doxorubicin and improved tumor accumulation
Asian Journal of Pharmaceutical Sciences
Magnetic mesoporous silica nanoparticles
Doxorubicin
pH-depended release
Tumor accumulation
author_facet Erxi Che
Long Wan
Ying Zhang
Qinfu Zhao
Xiling Han
Jia Li
Jia Liu
Siling Wang
author_sort Erxi Che
title Development of phosphonate-terminated magnetic mesoporous silica nanoparticles for pH-controlled release of doxorubicin and improved tumor accumulation
title_short Development of phosphonate-terminated magnetic mesoporous silica nanoparticles for pH-controlled release of doxorubicin and improved tumor accumulation
title_full Development of phosphonate-terminated magnetic mesoporous silica nanoparticles for pH-controlled release of doxorubicin and improved tumor accumulation
title_fullStr Development of phosphonate-terminated magnetic mesoporous silica nanoparticles for pH-controlled release of doxorubicin and improved tumor accumulation
title_full_unstemmed Development of phosphonate-terminated magnetic mesoporous silica nanoparticles for pH-controlled release of doxorubicin and improved tumor accumulation
title_sort development of phosphonate-terminated magnetic mesoporous silica nanoparticles for ph-controlled release of doxorubicin and improved tumor accumulation
publisher Elsevier
series Asian Journal of Pharmaceutical Sciences
issn 1818-0876
publishDate 2014-12-01
description In this study, phosphonate-terminated magnetic mesoporous nanoparticles (pMMSNs) was designed by incorporation of MNPs in the center of mesoporous silica nanoparticles (MSNs) and followed by grafting phosphonate group on to the surface of MMSNs. The carrier exhibited a typical superparamagnetic feature and the saturation magnetization was 4.89 emu/g measured by vibrating sample magnetometer (VSM). pMMSNs had a spherical morphology and a pore size of 2.2 nm. From N2 adsorption-desorption analysis, pMMSNs had a surface area of 613.4 m2/g and a pore volume of 0.78 cm3/g. Phosphonate modification improved the colloidal stability of MMSNs, and the hydrodynamic diameter of pMMSNs was around 175 nm. The hydrophilic phosphonate group significantly enhanced the negative surface charge of MMSNs from −19.3 mV to −28.8 mV pMMSNs with more negative surface charge had a 2.3-fold higher drug loading capacity than that of MMSNs. In addition, the rate and amount of release of doxorubicin (DOX) from DOX/pMMSNs was pH-dependent and increased with the decrease of pH. At pH 7.4, the release amount was quite low and only approximately 17 wt% of DOX was released in 48 h. At pH 5.0 and 3.0, the release rate increased significantly and the release amount achieved 31 wt% and 60 wt% in 48 h, respectively. To evaluate the magnetic targeting performance of pMMSNs, FITC labeled pMMSNs was injected into mice bearing S180 solid tumor. FITC labeled pMMSNs controlled by an external magnetic field showed higher tumor accumulation and lower normal tissue distribution.
topic Magnetic mesoporous silica nanoparticles
Doxorubicin
pH-depended release
Tumor accumulation
url http://www.sciencedirect.com/science/article/pii/S1818087614000531
work_keys_str_mv AT erxiche developmentofphosphonateterminatedmagneticmesoporoussilicananoparticlesforphcontrolledreleaseofdoxorubicinandimprovedtumoraccumulation
AT longwan developmentofphosphonateterminatedmagneticmesoporoussilicananoparticlesforphcontrolledreleaseofdoxorubicinandimprovedtumoraccumulation
AT yingzhang developmentofphosphonateterminatedmagneticmesoporoussilicananoparticlesforphcontrolledreleaseofdoxorubicinandimprovedtumoraccumulation
AT qinfuzhao developmentofphosphonateterminatedmagneticmesoporoussilicananoparticlesforphcontrolledreleaseofdoxorubicinandimprovedtumoraccumulation
AT xilinghan developmentofphosphonateterminatedmagneticmesoporoussilicananoparticlesforphcontrolledreleaseofdoxorubicinandimprovedtumoraccumulation
AT jiali developmentofphosphonateterminatedmagneticmesoporoussilicananoparticlesforphcontrolledreleaseofdoxorubicinandimprovedtumoraccumulation
AT jialiu developmentofphosphonateterminatedmagneticmesoporoussilicananoparticlesforphcontrolledreleaseofdoxorubicinandimprovedtumoraccumulation
AT silingwang developmentofphosphonateterminatedmagneticmesoporoussilicananoparticlesforphcontrolledreleaseofdoxorubicinandimprovedtumoraccumulation
_version_ 1725247112826847232